In another study, silencing of HuR combined with epirubicin treatment on a colon cancer cell line resulted in the suppression of drug resistance genes like MRP1 and P-gp at both mRNA and protein levels. The gene discussed is ELAVL1; the disease is malignant colon neoplasm.